127 related articles for article (PubMed ID: 27511603)
1. PRDM16 is associated with evasion of apoptosis by prostatic cancer cells according to RNA interference screening.
Zhu S; Xu Y; Song M; Chen G; Wang H; Zhao Y; Wang Z; Li F
Mol Med Rep; 2016 Oct; 14(4):3357-61. PubMed ID: 27511603
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of selected histone methylases and demethylases in prostate carcinoma.
Vieira FQ; Costa-Pinheiro P; Ramalho-Carvalho J; Pereira A; Menezes FD; Antunes L; Carneiro I; Oliveira J; Henrique R; Jerónimo C
Endocr Relat Cancer; 2014 Feb; 21(1):51-61. PubMed ID: 24200674
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of short hairpin RNA targeting integrin-linked kinase in prostate cancer cells.
Yuan Y; Xiao Y; Li Q; Liu Z; Zhang X; Qin C; Xie J; Wang X; Xu T
Mol Med Rep; 2013 Aug; 8(2):419-24. PubMed ID: 23783575
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Zhang Y; Yan L; Yao W; Chen K; Xu H; Ye Z
Med Sci Monit; 2019 Jan; 25():193-239. PubMed ID: 30616239
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific RNA interference targeting Pokemon suppresses tumor growth and induces apoptosis in prostate cancer.
Li Y; Xu S; Wang X; Shi H; Sun Z; Yang Z
Urology; 2013 Feb; 81(2):467.e1-7. PubMed ID: 23374847
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
7. SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.
Vieira FQ; Costa-Pinheiro P; Almeida-Rios D; Graça I; Monteiro-Reis S; Simões-Sousa S; Carneiro I; Sousa EJ; Godinho MI; Baltazar F; Henrique R; Jerónimo C
Oncotarget; 2015 May; 6(15):13644-57. PubMed ID: 25980436
[TBL] [Abstract][Full Text] [Related]
8. [Effect of gene GSTP1 silencing via shRNA transfection on androgen independent prostate cancer cell line Du145].
Jin P; Xie J; Zhu X; Zhou C; Ding X; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):807-16. PubMed ID: 22954916
[TBL] [Abstract][Full Text] [Related]
9. Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells.
White-Al Habeeb NM; Garcia J; Fleshner N; Bapat B
Prostate; 2016 Dec; 76(16):1507-1518. PubMed ID: 27404348
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of JNK-1 by small interfering RNA induces apoptotic signaling in PC-3 prostate cancer cells.
Parra E
Int J Mol Med; 2012 Oct; 30(4):923-30. PubMed ID: 22766602
[TBL] [Abstract][Full Text] [Related]
11. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.
Asirvatham AJ; Carey JP; Chaudhary J
Prostate; 2007 Sep; 67(13):1411-20. PubMed ID: 17639499
[TBL] [Abstract][Full Text] [Related]
12. Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.
Zhu J; Sun C; Wang L; Xu M; Zang Y; Zhou Y; Liu X; Tao W; Xue B; Shan Y; Yang D
Mol Med Rep; 2016 Feb; 13(2):1602-10. PubMed ID: 26718651
[TBL] [Abstract][Full Text] [Related]
13. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
14. Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell.
Pan B; Zheng S; Liu C; Xu Y
Mol Biol Rep; 2013 Jan; 40(1):27-33. PubMed ID: 23117283
[TBL] [Abstract][Full Text] [Related]
15. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
16. Influence of suppression of CapG gene expression by siRNA on the growth and metastasis of human prostate cancer cells.
Li BK; Guo K; Li CY; Li HL; Zhao PP; Chen K; Liu CX
Genet Mol Res; 2015 Dec; 14(4):15769-78. PubMed ID: 26634544
[TBL] [Abstract][Full Text] [Related]
17. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
Wang D; Zhu L; Liao M; Zeng T; Zhuo W; Yang S; Wu W
Oncol Rep; 2016 Sep; 36(3):1285-92. PubMed ID: 27431378
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
19. The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro.
Wang H; Gao X; Lu X; Wang Y; Ma C; Shi Z; Zhu F; He B; Xu C; Sun Y
Biosci Rep; 2015; 35(6):. PubMed ID: 26612002
[TBL] [Abstract][Full Text] [Related]
20. SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.
Liu C; Wang C; Wang K; Liu L; Shen Q; Yan K; Sun X; Chen J; Liu J; Ren H; Liu H; Xu Z; Hu S; Xu D; Fan Y
J Natl Cancer Inst; 2013 Nov; 105(22):1719-28. PubMed ID: 24174655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
